Department of Pharmacology, Johns Hopkins University School of Medicine, MD, USA.
Bioorg Med Chem. 2012 Mar 15;20(6):1902-9. doi: 10.1016/j.bmc.2011.11.070. Epub 2011 Dec 20.
Identification and validation of protein targets of bioactive small molecules is an important problem in chemical biology and drug discovery. Currently, no single method is satisfactory for this task. Here, we provide an overview of common methods for target identification and validation that historically were most successful. We have classified for the first time the existing methods into two distinct and complementary types, the 'top-down' and 'bottom-up' approaches. In a typical top-down approach, the cellular phenotype is used as a starting point and the molecular target is approached through systematic narrowing down of possibilities by taking advantage of the detailed existing knowledge of cellular pathways and processes. In contrast, the bottom-up approach entails the direct detection and identification of the molecular targets using affinity-based or genetic methods. A special emphasis is placed on target validation, including correlation analysis and genetic methods, as this area is often ignored despite its importance.
鉴定和验证生物活性小分子的蛋白靶标是化学生物学和药物发现中的一个重要问题。目前,没有单一的方法对此项任务是令人满意的。在这里,我们提供了一个概述的目标鉴定和验证,历史上最成功的常见方法。我们首次将现有的方法分为两种截然不同且互补的类型,即“自上而下”和“自下而上”的方法。在典型的自上而下的方法中,细胞表型用作起点,通过利用细胞途径和过程的详细现有知识,通过系统地缩小可能性,来接近分子靶标。相比之下,自下而上的方法需要使用基于亲和力或遗传的方法直接检测和鉴定分子靶标。特别强调目标验证,包括相关分析和遗传方法,因为尽管这很重要,但该领域经常被忽视。